TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biogen Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
50,880
|
57,548
|
61,158 |
| Financial expenses |
2
|
7
|
38 |
| Earnings before taxes |
2,021
|
2,206
|
2,156 |
| EBITDA |
1,893
|
2,049
|
2,219 |
| Total assets |
22,631
|
22,781
|
22,511 |
| Current assets |
22,594
|
22,764
|
22,479 |
| Current liabilities |
4,336
|
5,422
|
6,876 |
| Equity capital |
17,208
|
16,212
|
14,476 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
23
|
28
|
31 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.0%
|
71.2%
|
64.3% |
| Turnover per employee |
2,212
|
2,055
|
1,973 |
| Profit as a percentage of turnover |
4.0%
|
3.8%
|
3.5% |
| Return on assets (ROA) |
8.9%
|
9.7%
|
9.7% |
| Current ratio |
521.1%
|
419.8%
|
326.9% |
| Return on equity (ROE) |
11.7%
|
13.6%
|
14.9% |
| Change turnover |
-4,711
|
-3,788
|
-7,512 |
| Change turnover % |
-8%
|
-6%
|
-11% |
| Chg. No. of employees |
-5
|
-3
|
0 |
| Chg. No. of employees % |
-18%
|
-10%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.